These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21386104)

  • 1. Hypothesis: in COPD, a pound of cure may be better than an ounce of prevention.
    Rennard SI; Vestbo J
    Thorax; 2011 Aug; 66(8):643-5. PubMed ID: 21386104
    [No Abstract]   [Full Text] [Related]  

  • 2. Republished editorial: hypothesis: in COPD, a pound of cure may be better than an ounce of prevention.
    Rennard SI; Vestbo J
    Postgrad Med J; 2011 Dec; 87(1034):793-4. PubMed ID: 22121250
    [No Abstract]   [Full Text] [Related]  

  • 3. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exacerbation in chronic obstructive lung disease--better prevention and treatment. The Danish Society of Pulmonary Medicine].
    Vestbo J; Ulrik CS
    Ugeskr Laeger; 2003 Mar; 165(12):1243. PubMed ID: 12701293
    [No Abstract]   [Full Text] [Related]  

  • 5. [Two points concerning the prevention and management of chronic obstructive pulmonary diseases].
    Zhao M
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):577-8. PubMed ID: 11770415
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of patient-centered outcomes in defining the clinical course of chronic obstructive pulmonary disease. Introduction.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):1-3. PubMed ID: 16996893
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.
    Decramer M; Gosselink R; Rutten-Van Mölken M; Buffels J; Van Schayck O; Gevenois PA; Pellegrino R; Derom E; De Backer W
    Thorax; 2005 Apr; 60(4):335-42. PubMed ID: 15790991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study.
    Miravitlles M; Izquierdo I; Herrejón A; Torres JV; Baró E; Borja J;
    Respir Med; 2011 May; 105(5):740-7. PubMed ID: 21227672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Howling for the moon.
    Barnes N; Bush A
    Thorax; 2011 Aug; 66(8):645-6. PubMed ID: 21415246
    [No Abstract]   [Full Text] [Related]  

  • 11. [Impact of exacerbations and admissions in chronic obstructive pulmonary disease].
    Arnedillo Muñoz A
    Arch Bronconeumol; 2010; 46 Suppl 8():8-14. PubMed ID: 21334550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of COPD: the sooner the better?
    Decramer M; Cooper CB
    Thorax; 2010 Sep; 65(9):837-41. PubMed ID: 20805184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It's about time--directing our attention toward modifying the course of COPD.
    Cazzola M; Hanania NA; Jones PW; Mahler DA; Make B; Ohar J; Rennard S
    Respir Med; 2008 Jun; 102 Suppl 1():S37-48. PubMed ID: 18582796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting development and progression of COPD.
    Quanjer PH; Steenbruggen I; Ruppel G; Swanney MP
    Thorax; 2008 Nov; 63(11):1027-8; author reply 1028. PubMed ID: 18984822
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
    Goossens LM; Nivens MC; Sachs P; Monz BU; Rutten-van Mölken MP
    Respir Med; 2011 Aug; 105(8):1195-202. PubMed ID: 21439807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammation and progression of COPD.
    Vestbo J
    Thorax; 2007 Jun; 62(6):469-70. PubMed ID: 17536027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular hyperpermeability in COPD airways.
    Minakata Y; Nakanishi M; Hirano T; Matsunaga K; Yamagata T; Ichinose M
    Thorax; 2005 Oct; 60(10):882. PubMed ID: 16055610
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. What effect do inhaled steroids have on delaying the progression of COPD?
    Hansen L; Havemann J; Burroughs M; Lo V
    J Fam Pract; 2004 Oct; 53(10):835-6. PubMed ID: 15469782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reducing smoking by half in COPD patients: Does it reduce FEV1 decline?].
    Peiffer G; Perriot J; Underner M
    Rev Mal Respir; 2017 Mar; 34(3):177-179. PubMed ID: 28209421
    [No Abstract]   [Full Text] [Related]  

  • 20. Physiologic limitations during daily life activities in COPD patients.
    Lahaije AJ; van Helvoort HA; Dekhuijzen PN; Heijdra YF
    Respir Med; 2010 Aug; 104(8):1152-9. PubMed ID: 20346641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.